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http://intl.elsevierhealth.com/journals/ijidThe etiologic agents of many emerging infectious diseases
are thought to originate in animal reservoirs1 and, after
becoming established in the human population, to spread
by direct human-to-human contact. The crossing of species
barriers is historically credited with some of the most devas-
tating and unconventional outbreaks, and pandemic influ-
enza, Creutzfeldt—Jacob disease, West Nile virus, severe
acute respiratory syndrome (SARS), and HIV represent some
of the notable examples still vivid in public memory.1—4
One of the major public health crises we are currently
witnessing is the one linked to methicillin-resistant Staphy-
lococcus aureus (MRSA). While MRSA is easily transmitted
among humans by direct skin-to-skin contact, by contact with
infected biological material or contaminated personal
objects, or through the airborne route, food-initiated out-
breaks are increasingly implicated in human infections.5
Several reports reveal that this pathogen can be isolated
from cattle, pig, and chicken samples in slaughterhouses6
and from food samples randomly tested in supermarkets.7,8
At the same time, a thought-provoking phenomenon is
currently unraveling. Although MRSA has historically been
associated with healthcare and has become known as hospi-
tal-associated MRSA, it increasingly emerges without rela-
tionship to healthcare, in patients without apparent risk
factors, as a distinct epidemiological, microbiological, and
clinical entity known as community-associated MRSA.9,10 The
prevalence of community-associated MRSA, as revealed by a
recent study conducted on 2636 patients with skin and skin
structure S. aureus infections, increased from 9% in 2004 to
16% in 2005 and 21% in 2006.11 At the same time, growing
epidemiological and genetic evidence points towards
MRSA transmission across species, and unveils a previously
unknown face that this microorganism is assuming, as an
emerging zoonotic pathogen. The surge in community-asso-
ciated MRSA, at a time when reports of animal-to-human
transmission are increasing, might not be merely coinciden-
tal,12,13 and according to a recent study conducted in the
Netherlands, MRSA that entered from an animal reservoir
into the human population is now responsible for over 20% of
the strains isolated.14
Findings that have accumulated in recent years make it
necessary to define three additional patient groups at high1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.09.008risk for zoonotic MRSA: individuals in contact with farm
animals, contacts of household pets, and veterinarian staff.
In 2003, a new non-typeable MRSA strain was identified in
the Netherlands and linked to animal farming; subsequent
studies supported the possibility of farm workers becoming
infected from farm animals.14—19 Non-typeability with Sma I
by pulsed field gel electrophoresis has emerged over the
years as a shared characteristic of MRSA strains originating
in pigs,20 and currently over 39% of slaughterhouse pigs in the
Netherlands are estimated to be positive for non-typeable
MRSA isolates.21 In the Netherlands, 23% of pig farmers19 and
32% of farm workers exposed to pigs and veal calves17 were
found to be colonized with MRSA, rates that exceed 760 and
1000 times, respectively, those seen in the general popula-
tion, and that outweigh those reported for any other popula-
tion described so far. A similar study conducted among pig
farmers in North America found colonization rates of 20%,22
supporting the possibility that pigs represent reservoirs for
human MRSA infections irrespective of the geographic area.
Moreover, it is important to note that MRSA strains of animal
origin have been isolated from people lacking previous docu-
mented direct animal contacts, supporting the possibility
that direct human-to-human transmission occurs subsequent
to one person’s colonization/infection. After a female
patient was diagnosed with MRSA mastitis,18 her farmer
husband, their baby girl, and three co-workers from the same
farm were found to be colonized, as were eight out of 10
randomly chosen pigs. The strain isolated from the baby was
genetically identical to the one isolated from her parents,18
despite her lack of direct contact with farm animals. In
another example, MRSA was found in the screening cultures
of a 6-month-old girl before thoracic surgery, and subse-
quently her parents were found to be colonized as well,
presumably from a pig that the family raised on the farm.19
MRSA transmission also occurs, in both directions,
between humans and household animals. Owners have been
shown to infect pets, and these pets may subsequently act as
reservoirs to infect and/or re-infect susceptible hosts.13
Several studies underscore the possibility of pet dogs colo-
nizing household contacts.13,23—25 A diabetic patient and his
wife exhibited recurrent MRSA leg infections and cellulitis,
respectively, and both were cured only after their dog wasPublished by Elsevier Ltd. All rights reserved.
300 Editorialtreated as well.25 Remarkably, MRSA was isolated from a
kitten for up to 9 months after the initial diagnosis, an
alarming finding that points towards the possibility of pro-
longed colonization of pets and the subsequent increased risk
of transmission to household members.13
Veterinary clinic personnel represent the third group at
risk for MRSA colonization and/or infection. Very similar
MRSA strains have been isolated from animals and animal
care staff.26 As recently pointed out,27 MRSA carriage is
significantly higher (3.9% vs. 0.7%) among veterinary practi-
tioners than among individuals without professional exposure
to animals. The screening of 80 veterinary students and 99
veterinarians in the Netherlands28 revealed a 4.6% preva-
lence of MRSA carriage in this group, while other surveys
performed on international veterinary conference attendees
have reported MRSA colonization rates of 6.5%,29 10.1%,30
and 12.5%,31 values that exceed, by far, MRSA prevalence in
the general population, estimated to range between 0.03%
and 3%.32—34 Professionals with frequent animal contact
(daily or 5 hours/week) were found to have the highest risk
for colonization. However, as revealed by a recent study on
personnel working with neonatal horses, contacts as short as
4 hours are sufficient for the infection of veterinary person-
nel.12 These findings have prompted the suggestion that
veterinary personnel, when managing skin and skin-related
soft tissue MRSA infections, should always consider previous
contacts with animals.12
In the context of these findings, the defining of additional
groups at high risk for MRSA colonization and infection
emerges as an urgent task. Recent hospitalizations, outpa-
tient visits, nursing home admissions, antibiotic exposure,
chronic illness, and injection drug use are some of the most
important MRSA risk factors.34,35 However, maintaining a high
index of suspicion in animal farmers and their families, pet
owners, and professionals involved in animal care is essen-
tial, particularly when no apparent risk factors can be iden-
tified or when infections recur despite initial successful
treatment. Moreover, besides the medical aspect, it is impor-
tant to reflect on the broader public health perspective.
Zoonotic colonization of these high-risk groups can provide
the initial MRSA port of entry into the human population,
facilitating subsequent direct human-to-human transmis-
sion–—an alarming scenario, especially if we recall the
H5N1 influenza virus, for which human-to-human transmis-
sion was proposed to represent the last barrier needed to
unleash a pandemic.36
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